This outcome could be explained by the decrease of IL-1B and TNF-α levels, reversing the suppressing effects of Pilocarpine (epilepsy inducer) on antioxidant enzymes including SOD, CAT, and GSH. This evidence concerns the gene IL1B and epilepsy.